AYTU BIOPHARMA, INC Net Cash Provided by (Used in) Investing Activities, Continuing Operations
AYTU BIOPHARMA, INC (AYTU) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$82.09 thousand for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-14
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$69.90K.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $539.05K.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$1.28M.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$2.29M.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$3.53M.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$5.30M.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$1.00M.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$9.30K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$69.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | -$82.09K 10-Q · filed 2018-05-14 | ||
| 2017-12-31 | -$12.20K 10-Q · filed 2018-02-08 | |||
| 2017-06-30 | $539.05K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | -$739.66K derived: sum of 2 quarters · filed 2018-05-14 | -$3.03M derived: sum of 3 quarters · filed 2018-05-14 | -$3.53M 10-K · filed 2017-08-31 |
| 2017-03-31 | -$1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | -$3.57M derived: sum of 2 quarters · filed 2018-05-14 | -$4.07M 10-Q · filed 2018-05-14 | -$8.64M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | -$2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | -$2.79M 10-Q · filed 2018-02-08 | -$7.36M derived: sum of 3 quarters · filed 2018-02-08 | -$7.44M derived: sum of 4 quarters · filed 2018-02-08 |
| 2016-09-30 | -$504.72K 10-Q · filed 2017-11-09 | -$5.07M derived: sum of 2 quarters · filed 2017-11-09 | -$5.15M derived: sum of 3 quarters · filed 2017-11-09 | -$5.81M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | -$4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | -$4.64M derived: sum of 2 quarters · filed 2017-08-31 | -$5.30M derived: sum of 3 quarters · filed 2017-08-31 | -$5.30M 10-K · filed 2017-08-31 |
| 2016-03-31 | -$78.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | -$738.02K derived: sum of 2 quarters · filed 2017-05-11 | -$741.58K 10-Q · filed 2017-05-11 | -$1.74M derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | -$659.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$663.16K 10-Q · filed 2017-02-09 | -$1.67M derived: sum of 3 quarters · filed 2017-02-09 | -$1.67M derived: sum of 4 quarters · filed 2017-02-09 |
| 2015-09-30 | -$3.55K 10-Q · filed 2016-11-07 | -$1.01M derived: sum of 2 quarters · filed 2016-11-07 | -$1.01M derived: sum of 3 quarters · filed 2016-11-07 | |
| 2015-06-30 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | -$1.00M derived: sum of 2 quarters · filed 2016-09-01 | -$1.00M 10-K · filed 2016-09-01 | |
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11 | -$2.00K 10-Q · filed 2016-05-11 | ||
| 2014-12-31 | -$2.00K 10-Q · filed 2016-02-11 | |||
| 2014-06-30 | -$9.30K 10-K · filed 2015-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |